How the Oncotarget Journal is Contributing to the Advancement of Scientific Research
Oncotarget and Therapy has a Journal Impact Factor (JIF) of 2.272. It has been indexed severally by Biological Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Journal Citation Reports/Science Edition among several others. With all that, publishing with Oncotarget and Therapy comes with a lot of benefits, some of which are discussed in this article.
Advantages of Publishing with Oncotarget and Therapy
Oncotarget and Therapy is an electronic Journal, which means that it has an unlimited space to publish as many papers as there can be. This is different from other journals to which some paper authors can be turned away because of lack of space to publish their work. On matters of size, on the other hand, the journal can accommodate papers of any size. Upon publishing with the journal, an author is guaranteed of a global audience since papers are downloadable from www.dovepress.com at no charge. Download output styles at Endnote.com.
Oncotarget and Therapy is a peer-reviewed journal. For this reason, authors publishing with the journal are privileged to have their papers reviewed whereby observations by reviewers are necessary for paper ratings. The decision-making process in most journals is sluggish and lengthy, making papers from authors stall for a long time before they are published. For Oncotarget and Therapy, the case is different. After a paper is submitted, a decision about it is reached at a time not exceeding four weeks; peer-review is done in three weeks or less while the editor takes not more than seven days. With this speedy process, Oncotarget and Therapy lead to zero author frustrations.
For maximum benefits, authors are given the option of joining the Oncotarget and Therapy’s Favored Author Program. Upon joining the program, authors are accorded extra benefits, such as getting a personal coordinator, paper fast-tracking, and discounted publication processing fee.
Oncotarget is a journal that publishes medical papers on a weekly basis. The papers can be obtained from authors across almost all medical disciplines. Through the journal, findings from the scientific research are made readily accessible to the public, and medical specialists can exchange notes freely and quickly. Most importantly, scientists from all corners of the world are provided with a platform to contribute to the field of science. Learn more about Oncotarget at Research Gate.